Ranking age-specific modifiable risk factors for cardiovascular disease and mortality: evidence from a population-based longitudinal study

[1]  Y. Yano,et al.  Age‐Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease , 2023, Journal of the American Heart Association.

[2]  Yuan Ma,et al.  Age- and sex-specific modifiable risk factor profiles of dementia: evidence from the UK Biobank , 2023, European Journal of Epidemiology.

[3]  Z. Qian,et al.  Exposure to Air Pollution during Pre-Hypertension and Subsequent Hypertension, Cardiovascular Disease, and Death: A Trajectory Analysis of the UK Biobank Cohort , 2023, Environmental health perspectives.

[4]  P. López-Jaramillo,et al.  Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study , 2022, The Lancet.

[5]  U. Ekelund,et al.  Physical activity, diet quality and all-cause cardiovascular disease and cancer mortality: a prospective study of 346 627 UK Biobank participants , 2022, British Journal of Sports Medicine.

[6]  G. Heiss,et al.  Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US , 2022, JAMA network open.

[7]  Rajeev Gupta,et al.  Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. , 2022, European heart journal.

[8]  F. Lu,et al.  Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy. , 2022, European heart journal.

[9]  A. F. Boing,et al.  Air Pollution, Socioeconomic Status, and Age-Specific Mortality Risk in the United States , 2022, JAMA network open.

[10]  N. Samani,et al.  Long-term trends in the epidemiology of cardiovascular diseases in the UK: Insights from the British Heart Foundation Statistical Compendium. , 2022, Cardiovascular research.

[11]  C. Haiman,et al.  Joint Associations of Race, Ethnicity, and Socioeconomic Status With Mortality in the Multiethnic Cohort Study , 2022, JAMA network open.

[12]  S. Achenbach,et al.  Epidemiology of cardiovascular disease in Europe , 2021, Nature Reviews Cardiology.

[13]  Yu Xu,et al.  Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study. , 2021, The Lancet. Healthy longevity.

[14]  G. Livingston,et al.  Differences in the potential for dementia prevention between major ethnic groups within one country: A cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand , 2021, The Lancet regional health. Western Pacific.

[15]  T. H. Nguyen,et al.  Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 , 2021, Lancet.

[16]  S. Jebb,et al.  Associations between dietary patterns and the incidence of total and fatal cardiovascular disease and all-cause mortality in 116,806 individuals from the UK Biobank: a prospective cohort study , 2021, BMC Medicine.

[17]  O. Franco,et al.  Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies , 2021, BMJ.

[18]  J. Danesh,et al.  Association Between Depressive Symptoms and Incident Cardiovascular Diseases. , 2020, JAMA.

[19]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[20]  P. Elliott,et al.  Education, biological ageing, all-cause and cause-specific mortality and morbidity: UK biobank cohort study , 2020, EClinicalMedicine.

[21]  A. Keech,et al.  Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials , 2020, The Lancet.

[22]  S. Larsson,et al.  Alcohol Consumption and Cardiovascular Disease , 2020, Circulation. Genomic and precision medicine.

[23]  M. Brauer,et al.  Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study , 2020, The Lancet.

[24]  P. Sanders,et al.  Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort. , 2020, European heart journal.

[25]  L. Qi,et al.  Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. , 2019, European heart journal.

[26]  M. Pencina,et al.  Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention. , 2019, Journal of the American College of Cardiology.

[27]  M. Gulati,et al.  Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions , 2018, Circulation.

[28]  M. O’Donnell,et al.  Estimating average attributable fractions with confidence intervals for cohort and case–control studies , 2018, Statistical methods in medical research.

[29]  K. Denton,et al.  Sex-specific differences in hypertension and associated cardiovascular disease , 2018, Nature Reviews Nephrology.

[30]  A. Hackshaw,et al.  Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports , 2018, British Medical Journal.

[31]  Kamlesh Khunti,et al.  Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study , 2017, European heart journal.

[32]  R. Carney,et al.  Depression and coronary heart disease , 2017, Nature Reviews Cardiology.

[33]  J. Pell,et al.  The association between physical activity and risk of mortality is modulated by grip strength and cardiorespiratory fitness: evidence from 498 135 UK-Biobank participants , 2016, European heart journal.

[34]  F. Paneni,et al.  Ageing, metabolism and cardiovascular disease , 2016, The Journal of physiology.

[35]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[36]  S. Banik.  Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost and age-specific associations in 1.25 million people , 2014, Journal of Neuroanaesthesiology and Critical Care.

[37]  Harry Hemingway,et al.  Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people , 2014, The Lancet.

[38]  David A Sinclair,et al.  The intersection between aging and cardiovascular disease. , 2012, Circulation research.

[39]  Z. Bloomgarden.  Diabetes and Cardiovascular Disease , 2011, Diabetes Care.

[40]  O. Gefeller,et al.  Sequential and average attributable fractions as aids in the selection of preventive strategies. , 1995, Journal of clinical epidemiology.

[41]  OUP accepted manuscript , 2022, European Heart Journal.

[42]  OUP accepted manuscript , 2022, European Heart Journal.

[43]  OUP accepted manuscript , 2022, European Heart Journal.

[44]  OUP accepted manuscript , 2021, Journal of the American Medical Informatics Association.

[45]  L. Weinehall,et al.  Income-related inequalities in cardiovascular disease from mid-life to old age in a Northern Swedish cohort: A decomposition analysis. , 2016, Social science & medicine.